Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2019 ASH Annual Meeting & Exposition
2019 Lynn Sage Breast Cancer Symposium
CHEST 2019
2019 Chemotherapy Foundation Symposium
RSNA 2019
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Podcasts
CME
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
Subscribe
Advertisement
Search Results
Advertisement
No results found for "Stuart Lichtman, MD"
Suggestions:
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
«
1
»
Advertisement
Advertisement
Dec
08
Today In Oncology
Next Big Advance After CAR T-Cell Therapy May Be the Bispecific Antibody Mosunetuzumab
Geriatric Assessment–Guided Multidisciplinary Care May Benefit Older Patients Undergoing HCT
Assessing Cancer Pain Management in the Era of the Opioid Epidemic
DUOX2 Mutation in Familial Thyroid Cancers
Sequencing of Enzalutamide and Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
View More
Advertisement
Most Read Stories
Checkpoint Inhibitor Pneumonitis: A Pulmonologist’s Perspective
Breast-Conserving Surgery and Partial-Breast Reirradiation in Patients With Ipsilateral Disease Recurrence
FDA Approves Atezolizumab in Combination With Chemotherapy for First-Line Treatment of Metastatic Nonsquamous NSCLC
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
'Oral Cryotherapy' for Patients Undergoing Oxaliplatin-Based Chemotherapy
View More